Works matching IS 10196439 AND DT 2022 AND VI 60 AND IP 2

Results: 11

Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels.

Published in:

International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5310

By:

Esser, Laura Kristin;
Branchi, Vittorio;
Shakeri, Farhad;
Simon, Adrian Georg;
Stephan, Carsten;
Kristiansen, Glen;
Buness, Andreas;
Schorle, Hubert;
Toma, Marieta Ioana

Publication type:

Article

Epigallocatechin-3-gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer-associated fibroblasts.

Published in:

International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5309

By:

Chen, Shuhai;
Nishi, Masaaki;
Morine, Yuji;
Shimada, Mitsuo;
Tokunaga, Takuya;
Kashihara, Hideya;
Takasu, Chie;
Yamada, Shinichiro;
Wada, Yuma

Publication type:

Article

Extracellular domain of semaphorin 5A serves a tumor-suppressing role by activating interferon signaling pathways in lung adenocarcinoma cells.

Published in:

International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5311

By:

Chen, Ming-Zhen;
Su, Li-Yu;
Ko, Pin-Hao;
Hsu, Ming-Hsuan;
Chuang, Li-Ling;
Chen, Li-Han;
Lu, Tzu-Pin;
Chuang, Eric Y.;
Chow, Lu-Ping;
Tsai, Mong-Hsun;
Hsu, Hsao-Hsun;
Lai, Liang-Chuan

Publication type:

Article

Arsenic compounds induce apoptosis by activating the MAPK and caspase pathways in FaDu oral squamous carcinoma cells.

Published in:

International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5308

By:

Wu, Su-Zhen;
Lan, Yu-Yan;
Chu, Chiao-Yun;
Wang, Yang-Kao;
Lee, Yi-Ping;
Chang, Hong-Yi;
Huang, Bu-Miin

Publication type:

Article

Obesity, colorectal cancer and MACC1 expression: A possible novel molecular association.

Published in:

International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5307

By:

Bähr, Ina;
Jaeschke, Lina;
Nimptsch, Katharina;
Janke, Jürgen;
Herrmann, Pia;
Kobelt, Dennis;
Kielstein, Heike;
Pischon, Tobias;
Stein, Ulrike

Publication type:

Article

Protein disulfide isomerase A1-associated pathways in the development of stratified breast cancer therapies.

Published in:

International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5306

By:

Bakker, Emyr Yosef;
Fujii, Masayuki;
Krstic-Demonacos, Marija;
Demonacos, Constantinos;
Alhammad, Rashed

Publication type:

Article

LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.

Published in:

International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5305

By:

Xiao, Qungen;
Dong, Minhai;
Cheng, Fangling;
Mao, Feng;
Zong, Weifeng;
Wu, Kang;
Wang, Heping;
Xie, Ruifan;
Wang, Baofeng;
Lei, Ting;
Guo, Dongsheng

Publication type:

Article

N6-methyladenosine upregulates miR-181d-5p in exosomes derived from cancer-associated fibroblasts to inhibit 5-FU sensitivity by targeting NCALD in colorectal cancer.

Published in:

International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5304

By:

Pan, Shengli;
Deng, Yingying;
Fu, Jun;
Zhang, Yuhao;
Zhang, Zhijin;
Qin, Xianju

Publication type:

Article

Functional assessment of miR-1291 in colon cancer cells.

Published in:

International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5303

By:

Wang, Jiaqi;
Yokoyama, Yuhki;
Hirose, Haruka;
Shimomura, Yuki;
Bonkobara, Saki;
Itakura, Hiroaki;
Kouda, Shihori;
Morimoto, Yoshihiro;
Minami, Kazumasa;
Takahashi, Hidekazu;
Shibata, Satoshi;
Kobayashi, Shogo;
Uemura, Mamoru;
Tanaka, Susumu;
Wu, Xin;
Tanaka, Shinji;
Mori, Masaki;
Yamamoto, Hirofumi

Publication type:

Article

Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review).

Published in:

International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5302

By:

Lu, Jiachen;
Ding, Jianing;
Liu, Zhaoxia;
Chen, Tingtao

Publication type:

Article

Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.

Published in:

International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5301

By:

Zhang, Xuefeng;
Liu, Na;
Ma, Danhua;
Liu, Ling;
Jiang, Lu;
Zhou, Yu;
Zeng, Xin;
Li, Jing;
Chen, Qianming

Publication type:

Article